Mitochondrial mutant Caenorhabditis elegans phosphoproteome

ABSTRACT: Inhibition of insulin/IGF-1 signaling (IIS) represents a promising avenue for the treatment of mitochondrial diseases, although many of the molecular mechanisms underlying this beneficial effect remain elusive. Here, we investigate the phosphoproteomic landscape of Caenorhabditis elegans with severe mitochondrial deficiency in the context of insulin signaling inhibition.

OTHER RELATED OMICS DATASETS IN: MTBLS794 GSE122902

INSTRUMENT(S):

ORGANISM(S): Caenorhabditis Elegans

TISSUE(S): Whole Body

SUBMITTER: Antonia Piazzesi  

LAB HEAD: Daniele Bano

PROVIDER: PXD011859 | Pride | 2019-02-13

REPOSITORIES: Pride